Biểu đồ giá cổ phiếu OSTX
OSTX Dự đoán giá cổ phiếu
OS Therapies Inc
Quay lại
OS Therapies Inc (OSTX) Dự đoán giá cổ phiếu
Thống kê chính
Giá đóng cửa trước
$1.73
Giá mở cửa
$1.74
Phạm vi ngày
$1.73 - $1.78
Phạm vi 52 tuần
$1.15 - $2.57
Khối lượng
468.6K
Khối lượng trung bình
579.5K
Tỷ suất cổ tức
--
EPS (TTM)
-0.96
Vốn hóa thị trường
$72.8M
OSTX là gì?
OS Therapies, Inc. operates as a clinical stage biopharmaceutical company. The company is headquartered in Rockville, Maryland and currently employs 4 full-time employees. The company went IPO on 2024-08-01. Its pipeline includes two drug technologies: OST-HER2 and OST-tADC. Its lead asset, OST-HER2, is an off-the-shelf immunotherapy, which is a type of cancer treatment that helps one’s immune system fight cancer, comprised of a genetically weakened and modified strain of Listeria monocytogenes, a species of bacteria that causes the infection listeriosis, that expresses HER2 peptides. OST-tADC is a tunable ADC with a plug-and-play platform that features tunable pH-sensitive silicone linkers (SiLinkers). Its clinical-stage cancer immunotherapy programs also include OST-AXAL for human papilloma virus (HPV)-associated cancers; OST-503 for non-small cell lung cancer (NSCLC) & glioblastoma; and OST-PSA for prostate cancer.
